Contineum Therapeutics
Thomas O. Schrader is a Senior Director of Chemistry at Contineum Therapeutics, previously serving as an Associate Director of Medicinal Chemistry at Arena Pharmaceuticals, Inc. With a Ph.D. in Synthetic Organic Chemistry from Boston College and a B.S. in Biological Sciences from Colorado State University, Thomas has a strong educational background in the field.
This person is not in any teams
Contineum Therapeutics
Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease.